Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1980 Jun;99(3):743–804.

The prostanoids in hemostasis and thrombosis: a review.

J B Smith
PMCID: PMC1903705  PMID: 6992594

Full text

PDF
741

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addonizio V. P., Strauss J. F., Macarak E. J., Colman R. W., Edmunds H., Jr Preservation of platelet number and function with prostaglandin E1 during total cardiopulmonary bypass in rhesus monkeys. Surgery. 1978 Jun;83(6):619–625. [PubMed] [Google Scholar]
  2. Adelstein R. S., Conti M. A. Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity. Nature. 1975 Aug 14;256(5518):597–598. doi: 10.1038/256597a0. [DOI] [PubMed] [Google Scholar]
  3. Ahern D. G., Downing D. T. Inhibition of prostaglandin biosynthesis by eicosa-5,8,11,14-tetraynoic acid. Biochim Biophys Acta. 1970 Sep 8;210(3):456–461. doi: 10.1016/0005-2760(70)90042-1. [DOI] [PubMed] [Google Scholar]
  4. Alfin-Slater R. B., Aftergood L. Essential fatty acids reinvestigated. Physiol Rev. 1968 Oct;48(4):758–784. doi: 10.1152/physrev.1968.48.4.758. [DOI] [PubMed] [Google Scholar]
  5. Ali M., Cerskus A. L., Zamecnik J., McDonald J. W. Synthesis of prostaglandin D2 and thromboxane B2 by human platelets. Thromb Res. 1977 Oct;11(4):485–496. doi: 10.1016/0049-3848(77)90202-x. [DOI] [PubMed] [Google Scholar]
  6. Anderson M. W., Crutchley D. J., Tainer B. E., Eling T. E. Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase. Prostaglandins. 1978 Oct;16(4):563–570. doi: 10.1016/0090-6980(78)90186-7. [DOI] [PubMed] [Google Scholar]
  7. Anggård E., Larsson C., Samuelsson B. The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-delta 13-reductase in tissues of the swine. Acta Physiol Scand. 1971 Mar;81(3):396–404. doi: 10.1111/j.1748-1716.1971.tb04914.x. [DOI] [PubMed] [Google Scholar]
  8. Anghileri L. J. Calcium binding to phospholipids from experimental tumors. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1972 Dec 29;78(4):337–344. doi: 10.1007/BF00284347. [DOI] [PubMed] [Google Scholar]
  9. Armstrong J. M., Lattimer N., Moncada S., Vane J. R. Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits. Br J Pharmacol. 1978 Jan;62(1):125–130. doi: 10.1111/j.1476-5381.1978.tb07014.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. BERGSTROEM S., DANIELSSON H., SAMUELSSON B. THE ENZYMATIC FORMATION OF PROSTAGLANDIN E2 FROM ARACHIDONIC ACID PROSTAGLANDINS AND RELATED FACTORS 32. Biochim Biophys Acta. 1964 Jul 15;90:207–210. doi: 10.1016/0304-4165(64)90145-x. [DOI] [PubMed] [Google Scholar]
  11. BERGSTROEM S., RYHAGE R., SAMUELSSON B., SJOEVALL J. PROSTAGLANDINS AND RELATED FACTORS. 15. THE STRUCTURES OF PROSTAGLANDIN E1, F1-ALPHA, AND F1-BETA. J Biol Chem. 1963 Nov;238:3555–3564. [PubMed] [Google Scholar]
  12. BIGELOW F. S. Serotonin activity in blood; measurements in normal subjects and in patients with thrombocythemia hemorrhagica, and other hemorrhagic states. J Lab Clin Med. 1954 May;43(5):759–773. [PubMed] [Google Scholar]
  13. BORCHGREVINK C. F., OWREN P. A. The hemostatic effect of normal platelets in hemophilia and factor V deficiency. The importance of clotting factors adsorbed on platelets for normal hemostasis. Acta Med Scand. 1961 Sep;170:375–383. doi: 10.1111/j.0954-6820.1961.tb00250.x. [DOI] [PubMed] [Google Scholar]
  14. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  15. BORN G. V., CROSS M. J. EFFECTS OF INORGANIC IONS AND OF PLASMA PROTEINS ON THE AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE. J Physiol. 1964 Mar;170:397–414. doi: 10.1113/jphysiol.1964.sp007340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Baenziger N. L., Dillender M. J., Majerus P. W. Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin. Biochem Biophys Res Commun. 1977 Sep 9;78(1):294–301. doi: 10.1016/0006-291x(77)91253-0. [DOI] [PubMed] [Google Scholar]
  17. Bang H. O., Dyerberg J., Hjøorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand. 1976;200(1-2):69–73. doi: 10.1111/j.0954-6820.1976.tb08198.x. [DOI] [PubMed] [Google Scholar]
  18. Bernert J. T., Jr, Sprecher H. Studies to determine the role rates of chain elongation and desaturation play in regulating the unsaturated fatty acid composition of rat liver lipids. Biochim Biophys Acta. 1975 Sep 19;398(3):354–363. doi: 10.1016/0005-2760(75)90186-1. [DOI] [PubMed] [Google Scholar]
  19. Best L. C., Martin T. J., Russell R. G., Preston F. E. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets. Nature. 1977 Jun 30;267(5614):850–852. doi: 10.1038/267850a0. [DOI] [PubMed] [Google Scholar]
  20. Bhat S. G., Yoshimoto T., Yamamoto S., Hayaishi O. Solubilization and partial purification of prostaglandin endoperoxide synthetase of rabbit kidney medulla. Biochim Biophys Acta. 1978 Jun 23;529(3):398–408. doi: 10.1016/0005-2760(78)90084-x. [DOI] [PubMed] [Google Scholar]
  21. Biermé R., Boneu B., Guiraud B., Pris J. Aspirin and recurrent painful toes and fingers in thrombocythaemia. Lancet. 1972 Feb 19;1(7747):432–432. doi: 10.1016/s0140-6736(72)90877-x. [DOI] [PubMed] [Google Scholar]
  22. Bills T. K., Smith J. B., Silver M. J. Metabolism of [14C]arachidonic acid by human platelets. Biochim Biophys Acta. 1976 Feb 23;424(2):303–314. doi: 10.1016/0005-2760(76)90198-3. [DOI] [PubMed] [Google Scholar]
  23. Bills T. K., Smith J. B., Silver M. J. Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin. J Clin Invest. 1977 Jul;60(1):1–6. doi: 10.1172/JCI108745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Bito L. Z., Baroody R. A. Impermeability of rabbit erythrocytes to prostaglandins. Am J Physiol. 1975 Dec;229(6):1580–1584. doi: 10.1152/ajplegacy.1975.229.6.1580. [DOI] [PubMed] [Google Scholar]
  25. Bito L. Z. Saturable, energy-dependent, transmembrane transport of prostaglandins against concentration gradients. Nature. 1975 Jul 10;256(5513):134–136. doi: 10.1038/256134a0. [DOI] [PubMed] [Google Scholar]
  26. Blackwell G. J., Flower R. J. 1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets. Prostaglandins. 1978 Sep;16(3):417–425. doi: 10.1016/0090-6980(78)90220-4. [DOI] [PubMed] [Google Scholar]
  27. Blackwell G. J., Flower R. J., Nijkamp F. P., Vane J. R. Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids. Br J Pharmacol. 1978 Jan;62(1):79–89. doi: 10.1111/j.1476-5381.1978.tb07009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Booyse F. M., Marr J., Yang D. C., Guiliani D., Rafelson M. E., Jr Adenosine cyclic 3',5'-monophosphate-dependent protein kinase from human platelets. Biochim Biophys Acta. 1976 Jan 23;422(1):60–72. doi: 10.1016/0005-2744(76)90008-5. [DOI] [PubMed] [Google Scholar]
  29. Borgeat P., Hamberg M., Samuelsson B. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. J Biol Chem. 1976 Dec 25;251(24):7816–7820. [PubMed] [Google Scholar]
  30. Bryant R. W., Feinmark S. J., Makheja A. N., Bailey J. M. Lipid metabolism in cultured cells. Synthesis of vasoactive thromboxane A2 from [14C]arachidonic acid culture lung fibroblasts. J Biol Chem. 1978 Nov 25;253(22):8134–8142. [PubMed] [Google Scholar]
  31. Bult H., Bonta I. L. Rat platelets aggregate in the absence of endogenous precursors of prostaglandin endoperoxides. Nature. 1976 Dec 2;264(5585):449–451. doi: 10.1038/264449a0. [DOI] [PubMed] [Google Scholar]
  32. Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976 Dec;12(6):897–913. doi: 10.1016/0090-6980(76)90125-8. [DOI] [PubMed] [Google Scholar]
  33. Burch J. W., Baenziger N. L., Stanford N., Majerus P. W. Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5181–5184. doi: 10.1073/pnas.75.10.5181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Burch J. W., Stanford N., Majerus P. W. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest. 1978 Feb;61(2):314–319. doi: 10.1172/JCI108941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. CONNOR W. E., HOAK J. C., WARNER E. D. Massive thrombosis produced by fatty acid infusion. J Clin Invest. 1963 Jun;42:860–866. doi: 10.1172/JCI104778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Cerskus A. L., Ali M., Zamecnik J., McDonald J. W. Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits. Thromb Res. 1978 Mar;12(3):549–553. doi: 10.1016/0049-3848(78)90325-0. [DOI] [PubMed] [Google Scholar]
  37. Chap H. J., Zwaal R. F., van Deenen L. L. Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim Biophys Acta. 1977 Jun 2;467(2):146–164. doi: 10.1016/0005-2736(77)90192-4. [DOI] [PubMed] [Google Scholar]
  38. Charo I. F., Feinman R. D., Detwiler T. C. Interrelations of platelet aggregation and secretion. J Clin Invest. 1977 Oct;60(4):866–873. doi: 10.1172/JCI108841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Charo I. F., Feinman R. D., Detwiler T. C., Smith J. B., Ingerman C. M., Silver M. J. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion. Nature. 1977 Sep 1;269(5623):66–69. doi: 10.1038/269066a0. [DOI] [PubMed] [Google Scholar]
  40. Christ-Hazelhof E., Nugteren D. H., Van Dorp D. A. Conversions of prostaglandin endoperoxides by glutathione-S-transferases and serum albumins. Biochim Biophys Acta. 1976 Dec 20;450(3):450–461. doi: 10.1016/0005-2760(76)90018-7. [DOI] [PubMed] [Google Scholar]
  41. Christ E. J., van Dorp D. A. Comparative aspects of prostaglandin biosynthesis in animal tissues. Biochim Biophys Acta. 1972 Aug 11;270(4):534–545. [PubMed] [Google Scholar]
  42. Cohen P., Derksen A. Comparison of phospholipid and fatty acid composition of human erythrocytes and platelets. Br J Haematol. 1969 Oct;17(4):359–371. doi: 10.1111/j.1365-2141.1969.tb01382.x. [DOI] [PubMed] [Google Scholar]
  43. Cooper B., Schafer A. I., Puchalsky D., Handin R. I. Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders. Blood. 1978 Sep;52(3):618–626. [PubMed] [Google Scholar]
  44. Corey E. J., Nicolaou K. C., Machida Y., Malmsten C. L., Samuelsson B. Synthesis and biological properties of a 9,11-azo-prostanoid: highly active biochemical mimic of prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3355–3358. doi: 10.1073/pnas.72.9.3355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Crane B. H., Maish T. L., Maddox Y. T., Corey E. J., Székely I., Ramwell P. W. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction. J Pharmacol Exp Ther. 1978 Jul;206(1):132–138. [PubMed] [Google Scholar]
  46. Czervionke R. L., Hoak J. C., Fry G. L. Effect of aspirin on thrombin-induced adherence of platelets to cultured cells from the blood vessel wall. J Clin Invest. 1978 Oct;62(4):847–856. doi: 10.1172/JCI109197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Czervionke R. L., Smith J. B., Fry G. L., Hoak J. C., Haycraft D. L. Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. J Clin Invest. 1979 May;63(5):1089–1092. doi: 10.1172/JCI109379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Czervionke R. L., Smith J. B., Hoak J. C., Fry G. L., Haycraft D. L. Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endothelium. Thromb Res. 1979;14(4-5):781–786. doi: 10.1016/0049-3848(79)90132-4. [DOI] [PubMed] [Google Scholar]
  49. Daniel J. L., Holmsen H., Adelstein R. S. Thrombin-stimulated myosin phosphorylation in intact platelets and its possible involvement secretion. Thromb Haemost. 1977 Dec 15;38(4):984–989. [PubMed] [Google Scholar]
  50. Danon A., Assouline G. Inhibition of prostaglandin biosynthesis by corticosteroids requires RNA and protein synthesis. Nature. 1978 Jun 15;273(5663):552–554. doi: 10.1038/273552a0. [DOI] [PubMed] [Google Scholar]
  51. Danon A., Heimberg M., Oates J. A. Enrichment of rat tissue lipids with fatty acids that are prostaglandin precursors. Biochim Biophys Acta. 1975 Jun 23;388(3):318–330. doi: 10.1016/0005-2760(75)90090-9. [DOI] [PubMed] [Google Scholar]
  52. Davey M. G., Lüscher E. F. Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature. 1967 Dec 2;216(5118):857–858. doi: 10.1038/216857a0. [DOI] [PubMed] [Google Scholar]
  53. Dawson W., Boot J. R., Cockerill A. F., Mallen D. N., Osborne D. J. Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung. Nature. 1976 Aug 19;262(5570):699–702. doi: 10.1038/262699a0. [DOI] [PubMed] [Google Scholar]
  54. Detwiler T. C., Feinman R. D. Kinetics of the thrombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium. Biochemistry. 1973 Jun 19;12(13):2462–2468. doi: 10.1021/bi00737a015. [DOI] [PubMed] [Google Scholar]
  55. Diczfalusy U., Falardeau P., Hammarström S. Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase. FEBS Lett. 1977 Dec 15;84(2):271–274. doi: 10.1016/0014-5793(77)80704-7. [DOI] [PubMed] [Google Scholar]
  56. Dusting G. J., Moncada S., Vane J. R. Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog. Eur J Pharmacol. 1978 May 1;49(1):65–72. doi: 10.1016/0014-2999(78)90222-4. [DOI] [PubMed] [Google Scholar]
  57. Dyerberg J., Bang H. O., Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr. 1975 Sep;28(9):958–966. doi: 10.1093/ajcn/28.9.958. [DOI] [PubMed] [Google Scholar]
  58. Dyerberg J., Bang H. O., Stoffersen E., Moncada S., Vane J. R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978 Jul 15;2(8081):117–119. doi: 10.1016/s0140-6736(78)91505-2. [DOI] [PubMed] [Google Scholar]
  59. Egan R. W., Paxton J., Kuehl F. A., Jr Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem. 1976 Dec 10;251(23):7329–7335. [PubMed] [Google Scholar]
  60. Ellis E. F., Oelz O., Roberts L. J., 2nd, Payne N. A., Sweetman B. J., Nies A. S., Oates J. A. Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science. 1976 Sep 17;193(4258):1135–1137. doi: 10.1126/science.959827. [DOI] [PubMed] [Google Scholar]
  61. Evans G., Packham M. A., Nishizawa E. E., Mustard J. F., Murphy E. A. The effect of acetylsalicyclic acid on platelet function. J Exp Med. 1968 Nov 1;128(5):877–894. doi: 10.1084/jem.128.5.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. FULCO A. J., MEAD J. F. Metabolism of essential fatty acids. VIII. Origin of 5,8,11-eicosatrienoic acid in the fat-deficient rat. J Biol Chem. 1959 Jun;234(6):1411–1416. [PubMed] [Google Scholar]
  63. Falardeau P., Hamberg M., Samuelsson B. Metabolism of 8,11,14-eicosatrienoic acid in human platelets. Biochim Biophys Acta. 1976 Aug 23;441(2):193–200. doi: 10.1016/0005-2760(76)90162-4. [DOI] [PubMed] [Google Scholar]
  64. Feinman R. D., Detwiler T. C. Platelet secretion induced by divalent cation ionophores. Nature. 1974 May 10;249(453):172–173. doi: 10.1038/249172a0. [DOI] [PubMed] [Google Scholar]
  65. Ferreira S. H., Moncada S., Vane J. R. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol. 1971 Jun 23;231(25):237–239. doi: 10.1038/newbio231237a0. [DOI] [PubMed] [Google Scholar]
  66. Firkin B., Firkin F., Stott L. Von Willebrand's disease type B: a newly defined bleeding diathesis. Aust N Z J Med. 1973 Jun;3(3):225–229. doi: 10.1111/j.1445-5994.1973.tb03086.x. [DOI] [PubMed] [Google Scholar]
  67. Fitzpatrick F. A., Bundy G. L., Gorman R. R., Honohan T. 9,11-epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets. Nature. 1978 Oct 26;275(5682):764–766. doi: 10.1038/275764a0. [DOI] [PubMed] [Google Scholar]
  68. Fitzpatrick F. A., Gorman R. R., Bundy G. L. An antiserum against 9,11-azo-15-hydroxyprosta-5,13-dienoic acid recognises and binds prostaglandin endoperoxides. Nature. 1978 May 25;273(5660):302–304. doi: 10.1038/273302a0. [DOI] [PubMed] [Google Scholar]
  69. Flower R. J., Blackwell G. J. The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem Pharmacol. 1976 Feb 1;25(3):285–291. doi: 10.1016/0006-2952(76)90216-1. [DOI] [PubMed] [Google Scholar]
  70. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  71. Friedman M., Van den Bovenkamp G. J. The pathogenesis of a coronary thrombus. Am J Pathol. 1966 Jan;48(1):19–44. [PMC free article] [PubMed] [Google Scholar]
  72. Fukami M. H., Holmsen H., Bauer J. Thrombin-induced oxygen consumption, malonyldialdehyde formation and serotonin secretion in human platelets. Biochim Biophys Acta. 1976 Mar 25;428(1):253–256. doi: 10.1016/0304-4165(76)90126-4. [DOI] [PubMed] [Google Scholar]
  73. Fukami M. H., Holmsen H., Salganicoff L. Adenine nucleotide metabolism of blood platelets. IX. Time course of secretion and changes in energy metabolism in thrombin-treated platelets. Biochim Biophys Acta. 1976 Oct 22;444(3):633–643. doi: 10.1016/0304-4165(76)90310-x. [DOI] [PubMed] [Google Scholar]
  74. GAARDER A., JONSEN J., LALAND S., HELLEM A., OWREN P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature. 1961 Nov 11;192:531–532. doi: 10.1038/192531a0. [DOI] [PubMed] [Google Scholar]
  75. GRETTE K. Studies on the mechanism of thrombin-catalyzed hemostatic reactions in blood platelets. Acta Physiol Scand Suppl. 1962;195:1–93. [PubMed] [Google Scholar]
  76. Ganguly P., Sonnichsen W. J. Binding of thrombin to human platelets and its possible significance. Br J Haematol. 1976 Oct;34(2):291–301. doi: 10.1111/j.1365-2141.1976.tb00199.x. [DOI] [PubMed] [Google Scholar]
  77. Gerrard J. M., Peller J. D., Krick T. P., White J. G. Cyclic AMP and platelet prostaglandin synthesis. Prostaglandins. 1977 Jul;14(1):39–50. doi: 10.1016/0090-6980(77)90155-1. [DOI] [PubMed] [Google Scholar]
  78. Gerrard J. M., White J. G., Rao G. H., Townsend D. Localization of platelet prostaglandin production in the platelet dense tubular system. Am J Pathol. 1976 May;83(2):283–298. [PMC free article] [PubMed] [Google Scholar]
  79. Gill J. R., Jr, Frölich J. C., Bowden R. E., Taylor A. A., Keiser H. R., Seyberth H. W., Oates J. A., Bartter F. C. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med. 1976 Jul;61(1):43–51. doi: 10.1016/0002-9343(76)90029-2. [DOI] [PubMed] [Google Scholar]
  80. Gjesdal K. Platelet function and plasma free fatty acids during acute myocardial infarction and severe angina pectoris. Scand J Haematol. 1976 Sep;17(3):205–212. doi: 10.1111/j.1600-0609.1976.tb01176.x. [DOI] [PubMed] [Google Scholar]
  81. Gordon J. L., Pearson J. D. Effects of sulphinpyrazone and aspirin on prostaglandin I2 (prostacyclin) synthesis by endothelial cells. Br J Pharmacol. 1978 Dec;64(4):481–483. doi: 10.1111/j.1476-5381.1978.tb17308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Gorman R. R., Bundy G. L., Peterson D. C., Sun F. F., Miller O. V., Fitzpatrick F. A. Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4007–4011. doi: 10.1073/pnas.74.9.4007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Gorman R. R., Bunting S., Miller O. V. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins. 1977 Mar;13(3):377–388. doi: 10.1016/0090-6980(77)90018-1. [DOI] [PubMed] [Google Scholar]
  84. Gorman R. R., Fitzpatrick F. A., Miller O. V. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2. Biochem Biophys Res Commun. 1977 Nov 7;79(1):305–313. doi: 10.1016/0006-291x(77)90096-1. [DOI] [PubMed] [Google Scholar]
  85. Granström E., Lands W. E., Samuelsson B. Biosynthesis of 9-alpha,15-dihydroxy-11-ketoprost-13-enoic acid. J Biol Chem. 1968 Aug 10;243(15):4104–4108. [PubMed] [Google Scholar]
  86. Granström E., Samuelsson B. On the metabolism of prostaglandin F 2 in female subjects. II. Structures of six metabolites. J Biol Chem. 1971 Dec 25;246(24):7470–7485. [PubMed] [Google Scholar]
  87. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. doi: 10.1016/0090-6980(76)90047-2. [DOI] [PubMed] [Google Scholar]
  88. Gryglewski R. J., Korbut R., Ocetkiewicz A. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation. Nature. 1978 Jun 29;273(5665):765–767. doi: 10.1038/273765a0. [DOI] [PubMed] [Google Scholar]
  89. Gryglewski R., Vane J. R. The release of prostaglandins and rabbit aorta contracting substance (RCS) from rabbit spleen and its antagonism by anti-inflammatory drugs. Br J Pharmacol. 1972 May;45(1):37–47. doi: 10.1111/j.1476-5381.1972.tb09574.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. HASLAM R. J. ROLE OF ADENOSINE DIPHOSPHATE IN THE AGGREGATION OF HUMAN BLOOD-PLATELETS BY THROMBIN AND BY FATTY ACIDS. Nature. 1964 May 23;202:765–768. doi: 10.1038/202765a0. [DOI] [PubMed] [Google Scholar]
  91. HIRSCH H., GAEHTGENS P., SOBBE A. ANDERUNGEN DES SIEBUNGSDRUCKS NACH ISCHAEMIE VON GEHIRN, EXTREMITAET UND NIERE. Pflugers Arch Gesamte Physiol Menschen Tiere. 1964 Oct 5;281:191–200. [PubMed] [Google Scholar]
  92. HOAK J. C., POOLE J. C., ROBINSON D. S. THROMBOSIS ASSOCIATED WITH MOBILIZATION OF FATTY ACIDS. Am J Pathol. 1963 Dec;43:987–998. [PMC free article] [PubMed] [Google Scholar]
  93. HOLMSEN H. COLLAGEN-INDUCED RELEASE OF ADENOSINE DIPHOSPHATE FROM BLOOD PLATELETS INCUBATED WITH RADIOACTIVE PHOSPHATE IN VITRO. Scand J Clin Lab Invest. 1965;17:239–246. [PubMed] [Google Scholar]
  94. HOVIG T. RELEASE OF A PLATELET-AGGREGATING SUBSTANCE (ADENOSINE DIPHOSPHATE) FROM RABBIT BLOOD PLATELETS INDUCED BY SALINE "EXTRACT" OF TENDONS. Thromb Diath Haemorrh. 1963 Jul 15;143:264–278. [PubMed] [Google Scholar]
  95. HUSSAIN O. Z., NEWCOM T. F. THROMBIN STIMULATION OF PLATELET OXYGEN CONSUMPTION RATE. J Appl Physiol. 1964 Mar;19:297–300. doi: 10.1152/jappl.1964.19.2.297. [DOI] [PubMed] [Google Scholar]
  96. Haerem J. W. Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis. 1972 Mar-Apr;15(2):199–213. doi: 10.1016/0021-9150(72)90070-6. [DOI] [PubMed] [Google Scholar]
  97. Hamberg M., Fredholm B. B. Isomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin. Biochim Biophys Acta. 1976 Apr 22;431(1):189–183. doi: 10.1016/0005-2760(76)90273-3. [DOI] [PubMed] [Google Scholar]
  98. Hamberg M. Inhibition of prostaglandin synthesis in man. Biochem Biophys Res Commun. 1972 Nov 1;49(3):720–726. doi: 10.1016/0006-291x(72)90470-6. [DOI] [PubMed] [Google Scholar]
  99. Hamberg M., Israelsson U. Metabolism of prostaglandin E2 in guinea pig liver. I. Identification of seven metabolites. J Biol Chem. 1970 Oct 10;245(19):5107–5114. [PubMed] [Google Scholar]
  100. Hamberg M. On the formation of thromboxane B2 and 12l-hydroxy-5,8,10,14-eicosatetraenoic acid (12 ho-20:4) in tissues from the guinea pig. Biochim Biophys Acta. 1976 Jun 22;431(3):651–654. doi: 10.1016/0005-2760(76)90232-0. [DOI] [PubMed] [Google Scholar]
  101. Hamberg M. Quantitative studies on prostaglandin synthesis in man. II. Determination of the major urinary metabolite of prostaglandins F1 alpha and F2 alpha. Anal Biochem. 1973 Oct;55(2):368–378. doi: 10.1016/0003-2697(73)90125-5. [DOI] [PubMed] [Google Scholar]
  102. Hamberg M., Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci U S A. 1973 Mar;70(3):899–903. doi: 10.1073/pnas.70.3.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Hamberg M., Samuelsson B. On the metabolism of prostaglandins E 1 and E 2 in man. J Biol Chem. 1971 Nov 25;246(22):6713–6721. [PubMed] [Google Scholar]
  104. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404. doi: 10.1073/pnas.71.9.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Hamberg M., Svensson J., Samuelsson B. Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc Natl Acad Sci U S A. 1974 Oct;71(10):3824–3828. doi: 10.1073/pnas.71.10.3824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci U S A. 1974 Feb;71(2):345–349. doi: 10.1073/pnas.71.2.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Hammarström S., Falardeau P. Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3691–3695. doi: 10.1073/pnas.74.9.3691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Hammarström S. Selective inhibition of platelet n-8 lipoxygenase by 5,8,11-eicosatriynoic acid. Biochim Biophys Acta. 1977 Jun 22;487(3):517–519. doi: 10.1016/0005-2760(77)90221-1. [DOI] [PubMed] [Google Scholar]
  110. Haslam R. J., Lynham J. A. Increased phosphorylation of specific blood platelet proteins in association with the release reaction. Biochem Soc Trans. 1976;4(4):694–697. doi: 10.1042/bst0040694. [DOI] [PubMed] [Google Scholar]
  111. Hawkings H. J., Smith J. B., Nicolaou K. C., Eling T. E. Studies of the mechanisms involved in the fate of prostacyclin (PGI2) and 6-keto-PGF1alpha in the pulmonary circulation. Prostaglandins. 1978 Dec;16(6):871–884. doi: 10.1016/0090-6980(78)90103-x. [DOI] [PubMed] [Google Scholar]
  112. Hemler M., Lands W. E. Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme. J Biol Chem. 1976 Sep 25;251(18):5575–5579. [PubMed] [Google Scholar]
  113. Hensby C. N. Distribution studies on the reduction of prostaglandin E2 to prostaglandin F2alpha by tissue homogenates. Biochim Biophys Acta. 1975 Nov 21;409(2):225–234. doi: 10.1016/0005-2760(75)90157-5. [DOI] [PubMed] [Google Scholar]
  114. Heyns A. P., van den Berg D. J., Potgieter G. M., Retief F. P. The inhibition of platelet aggregation by an aorta intima extract. Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):417–431. [PubMed] [Google Scholar]
  115. Hillis L. D., Braunwald E. Coronary-artery spasm. N Engl J Med. 1978 Sep 28;299(13):695–702. doi: 10.1056/NEJM197809282991305. [DOI] [PubMed] [Google Scholar]
  116. Ho P. P., Walters C. P., Sullivan H. R. A particulate arachidonate lipoxygenase in human blood platelets. Biochem Biophys Res Commun. 1976 May 23;76(2):398–405. doi: 10.1016/0006-291x(77)90738-0. [DOI] [PubMed] [Google Scholar]
  117. Ho P. P., Walters C. P., Sullivan H. R. Biosynthesis of thromboxane B2: assay, isolation, and properties of the enzyme system in human platelets. Prostaglandins. 1976 Dec;12(6):951–970. doi: 10.1016/0090-6980(76)90129-5. [DOI] [PubMed] [Google Scholar]
  118. Hoak J. C., Connor W. E., Warner E. D. Thrombogenic effects of albumin-bound fatty acids. Arch Pathol. 1966 Feb;81(2):136–139. [PubMed] [Google Scholar]
  119. Hoak J. C., Wu K. K., Fry G. L. Use of newer platelet function tests ot define abnormalities of hemostasis and thrombosis. Ser Haematol. 1975;8(3):81–88. [PubMed] [Google Scholar]
  120. Holmsen H., Day H. J., Storm E. Adenine nucleotide metabolism of blood platelets. VI. Subcellular localization of nucleotide pools with different functions in the platelet release reaction. Biochim Biophys Acta. 1969 Aug 20;186(2):254–266. doi: 10.1016/0005-2787(69)90003-3. [DOI] [PubMed] [Google Scholar]
  121. Holmsen H., Day H. J., Stormorken H. The blood platelet release reaction. Scand J Haematol Suppl. 1969;8:3–26. [PubMed] [Google Scholar]
  122. Holmsen H., Day H. J. The selectivity of the thrombin-induced platelet release reaction: subcellular localization of released and retained constituents. J Lab Clin Med. 1970 May;75(5):840–855. [PubMed] [Google Scholar]
  123. Holmsen H. Prostaglandin endoperoxide--thromboxane synthesis and dense granule secretion as positive feedback loops in the propagation of platelet responses during "the basic platelet reaction". Thromb Haemost. 1977 Dec 15;38(4):1030–1041. [PubMed] [Google Scholar]
  124. Hong S. L., Levine L. Stimulation of prostaglandin synthesis by bradykinin and thrombin and their mechanisms of action on MC5-5 fibroblasts. J Biol Chem. 1976 Sep 25;251(18):5814–5816. [PubMed] [Google Scholar]
  125. Hopkins N. K., Sun F. F., Gorman R. R. Thromboxane A2 biosynthesis in human lung fibroblasts WI-38. Biochem Biophys Res Commun. 1978 Nov 29;85(2):827–836. doi: 10.1016/0006-291x(78)91237-8. [DOI] [PubMed] [Google Scholar]
  126. Hsueh W., Isakson P. C., Needleman P. Hormone selective lipase activation in the isolated rabbit heart. Prostaglandins. 1977 Jun;13(6):1073–1091. doi: 10.1016/0090-6980(77)90135-6. [DOI] [PubMed] [Google Scholar]
  127. Humes J. L., Bonney R. J., Pelus L., Dahlgren M. E., Sadowski S. J., Kuehl F. A., Jr, Davies P. Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature. 1977 Sep 8;269(5624):149–151. doi: 10.1038/269149a0. [DOI] [PubMed] [Google Scholar]
  128. Ingerman C. M., Smith J. B., Shapiro S., Sedar A., Silver M. J. Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. Blood. 1978 Aug;52(2):332–344. [PubMed] [Google Scholar]
  129. Ireland D. M. Effect of thrombin on the radioactive nucleotides of human washed platelets. Biochem J. 1967 Nov;105(2):857–867. doi: 10.1042/bj1050857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Isakson P. C., Raz A., Denny S. E., Pure E., Needleman P. A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart. Proc Natl Acad Sci U S A. 1977 Jan;74(1):101–105. doi: 10.1073/pnas.74.1.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Jesse R. L., Cohen P. Arachidonic acid release from diacyl phosphatidylethanolamine by human platelet membranes. Biochem J. 1976 Aug 15;158(2):283–287. doi: 10.1042/bj1580283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Johnson R. A., Lincoln F. H., Thompson J. L., Nidy E. G., Mizak S. A., Axen U. Synthesis and sterochemistry of prostacyclin and synthesis of 6-ketoprostagliandin F1alpha. J Am Chem Soc. 1977 Jun 8;99(12):4182–4184. doi: 10.1021/ja00454a060. [DOI] [PubMed] [Google Scholar]
  133. Johnson R. A., Nidy E. G., Baczynskyj L., Gorman R. R. Synthesis of prostaglandin H2 methyl ester. J Am Chem Soc. 1977 Nov 9;99(23):7738–7740. doi: 10.1021/ja00465a071. [DOI] [PubMed] [Google Scholar]
  134. Jones R. L., Kerry P. J., Poyser N. L., Walker I. C., Wilson N. H. The identification of trihydroxyeicosatrienoic acids as products from the incubation of arachidonic acid with washed blood platelets. Prostaglandins. 1978 Oct;16(4):583–589. doi: 10.1016/0090-6980(78)90188-0. [DOI] [PubMed] [Google Scholar]
  135. Jorgensen L., Haerem J. W., Chandler A. B., Borchgrevink C. F. The pathology of acute coronary death. Acta Anaesthesiol Scand Suppl. 1968;29:193–201. doi: 10.1111/j.1399-6576.1968.tb00734.x. [DOI] [PubMed] [Google Scholar]
  136. KJAERHEIM A., HOVIG T. The ultrastructure of haemostatic blood platelet plugs in rabbit mesenterium. Thromb Diath Haemorrh. 1962 Mar 15;7:1–15. [PubMed] [Google Scholar]
  137. Kaneshiro M. M., Mielke C. H., Jr, Kasper C. K., Rapaport S. I. Bleeding time after aspirin in disorders of intrinsic clotting. N Engl J Med. 1969 Nov 6;281(19):1039–1042. doi: 10.1056/NEJM196911062811904. [DOI] [PubMed] [Google Scholar]
  138. Kaulen H. D., Gross R. Metabolic properties of human platelet membranes. II. Thrombin-induced phosphorylation of membrane lipids and demonstration of phosphorylating enzymes in the platelet membrane. Thromb Haemost. 1976 Apr 30;35(2):364–376. [PubMed] [Google Scholar]
  139. Kelton J. G., Hirsh J., Carter C. J., Buchanan M. R. Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity. J Clin Invest. 1978 Oct;62(4):892–895. doi: 10.1172/JCI109203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Kernoff P. B., Willis A. L., Stone K. J., Davies J. A., McNicol G. P. Antithrombotic potential of dihomo-gamma-linolenic acid in man. Br Med J. 1977 Dec 3;2(6100):1441–1444. doi: 10.1136/bmj.2.6100.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Kindahl H. Metabolism of thromboxane B2 in the cynomolgus monkey. Prostaglandins. 1977 Apr;13(4):619–629. doi: 10.1016/0090-6980(77)90233-7. [DOI] [PubMed] [Google Scholar]
  142. Kinlough-Rathbone R. L., Chahil A., Packham M. A., Reimers H. J., Mustard J. F. Effect of ionophore A23, 187 on thrombin-degranulated washed rabbit platelets. Thromb Res. 1975 Sep;7(3):435–449. doi: 10.1016/0049-3848(75)90038-9. [DOI] [PubMed] [Google Scholar]
  143. Kinlough-Rathbone R. L., Packham M. A., Mustard J. F. Synergism between platelet aggregating agents: the role of the arachidonate pathway. Thromb Res. 1977 Nov;11(5):567–580. doi: 10.1016/0049-3848(77)90016-0. [DOI] [PubMed] [Google Scholar]
  144. Kinlough-Rathbone R. L., Packham M. A., Mustard J. F. The effect of prostaglandin E1 on platelet function in vitro and in vivo. Br J Haematol. 1970 Nov;19(5):559–571. doi: 10.1111/j.1365-2141.1970.tb01639.x. [DOI] [PubMed] [Google Scholar]
  145. Kitchen E. A., Boot J. R., Dawson W. Chemotactic activity of thromboxane B2, prostaglandins and their metabolites for polymorphonuclear leucocytes. Prostaglandins. 1978 Aug;16(2):239–244. doi: 10.1016/0090-6980(78)90025-4. [DOI] [PubMed] [Google Scholar]
  146. Kloeze J. Relationship between chemical structure and platelet-aggregation activity of prostaglandins. Biochim Biophys Acta. 1969 Oct 28;187(3):285–292. doi: 10.1016/0005-2760(69)90001-0. [DOI] [PubMed] [Google Scholar]
  147. Kocsis J. J., Hernandovich J., Silver M. J., Smith J. B., Ingerman C. Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins. 1973 Feb;3(2):141–144. doi: 10.1016/0090-6980(73)90081-6. [DOI] [PubMed] [Google Scholar]
  148. Kulkarni P. S., Eakins K. E. N-0164 inhibits generation of thromboxane-A2-like activity from prostaglandin endoperoxides by human platelet microsomes. Prostaglandins. 1976 Sep;12(3):465–469. doi: 10.1016/0090-6980(76)90027-7. [DOI] [PubMed] [Google Scholar]
  149. Kulkarni P. S., Roberts R., Needleman P. Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate. Prostaglandins. 1976 Sep;12(3):337–353. doi: 10.1016/0090-6980(76)90015-0. [DOI] [PubMed] [Google Scholar]
  150. Kunze H., Bohn E., Vogt W. Effects of local anaesthetics on prostaglandin biosynthesis in vitro. Biochim Biophys Acta. 1974 Sep 19;360(3):260–269. doi: 10.1016/0005-2760(74)90055-1. [DOI] [PubMed] [Google Scholar]
  151. Kunze H., Vogt W. Significance of phospholipase A for prostaglandin formation. Ann N Y Acad Sci. 1971 Apr 30;180:123–125. doi: 10.1111/j.1749-6632.1971.tb53191.x. [DOI] [PubMed] [Google Scholar]
  152. Käser-Glanzmann R., Jakábová M., George J. N., Lüscher E. F. Further characterization of calcium-accumulating vesicles from human blood platelets. Biochim Biophys Acta. 1978 Sep 11;512(1):1–12. doi: 10.1016/0005-2736(78)90213-4. [DOI] [PubMed] [Google Scholar]
  153. Käser-Glanzmann R., Jakäbovä M., George J. N., Lüscher E. F. Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate and protein kinase. Biochim Biophys Acta. 1977 May 2;466(3):429–440. doi: 10.1016/0005-2736(77)90336-4. [DOI] [PubMed] [Google Scholar]
  154. Lagarde M., Byron P. A., Vargaftig B. B., Dechavanne M. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. Br J Haematol. 1978 Feb;38(2):251–266. doi: 10.1111/j.1365-2141.1978.tb01041.x. [DOI] [PubMed] [Google Scholar]
  155. Lagarde M., Gharib A., Dechavanne M. Different utilization of arachidonic and dihomogammalinolenic acids by human platelet prostaglandin synthetase. Biochimie. 1977;59(11-12):935–937. doi: 10.1016/s0300-9084(78)80710-x. [DOI] [PubMed] [Google Scholar]
  156. Lands W. E., Samuelsson B. Phospholipid precursors of prostaglandins. Biochim Biophys Acta. 1968 Oct 22;164(2):426–429. doi: 10.1016/0005-2760(68)90168-9. [DOI] [PubMed] [Google Scholar]
  157. Lapetina E. G., Chandrabose K. A., Cuatrecasas P. Ionophore A-23187- and thrombin-induced platelet aggregation: independence from cycloxygenase products. Proc Natl Acad Sci U S A. 1978 Feb;75(2):818–822. doi: 10.1073/pnas.75.2.818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Lapetina E. G., Schmitges C. J., Chandrabose K., Cuatrecases P. Cyclic adenosine 3',5'-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets. Biochem Biophys Res Commun. 1977 Jun 6;76(3):828–835. doi: 10.1016/0006-291x(77)91575-3. [DOI] [PubMed] [Google Scholar]
  159. Lee S. C., Levine L. Prostaglandin metabolism. I. Cytoplasmic reduced nicotinamide adenine dinucleotide phosphate-dependent and microsomal reduced nicotinamide adenine dinucleotide-dependent prostaglandin E 9-ketoreductase activities in monkey and pigeon tissues. J Biol Chem. 1974 Mar 10;249(5):1369–1375. [PubMed] [Google Scholar]
  160. Levine L., Wu K. Y., Pong S. S. Stereospecificity of enzymatic reduction of prostaglandin E2 to F2alpha. Prostaglandins. 1975 Apr;9(4):531–544. doi: 10.1016/0090-6980(75)90059-3. [DOI] [PubMed] [Google Scholar]
  161. Lewy R. I., Smith J. B., Silver M. J., Saia J., Walinsky P., Wiener L. Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina. Prostaglandins Med. 1979 Apr;2(4):243–248. doi: 10.1016/0161-4630(79)90059-4. [DOI] [PubMed] [Google Scholar]
  162. Lloyd J. V., Mustard J. F. Changes in 32P-content of phosphatidic acid and the phosphoinositides of rabbit platelets during aggregation induced by collagen or thrombin. Br J Haematol. 1974 Feb;26(2):243–253. doi: 10.1111/j.1365-2141.1974.tb00469.x. [DOI] [PubMed] [Google Scholar]
  163. Lloyd J. V., Nishizawa E. E., Haldar J., Mustard J. F. Changes in 32 p-labelling of platelet phospholipids in response to ADP. Br J Haematol. 1972 Nov;23(5):571–585. doi: 10.1111/j.1365-2141.1972.tb07092.x. [DOI] [PubMed] [Google Scholar]
  164. Lyons R. M., Stanford N., Majerus P. W. Thrombin-induced protein phosphorylation in human platelets. J Clin Invest. 1975 Oct;56(4):924–936. doi: 10.1172/JCI108172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. MARCHESI V. T., BARRNETT R. J. THE LOCALIZATION OF NUCLEOSIDEPHOSPHATASE ACTIVITY IN DIFFERENT TYPES OF SMALL BLOOD VESSELS. J Ultrastruct Res. 1964 Feb;10:103–115. doi: 10.1016/s0022-5320(64)90024-3. [DOI] [PubMed] [Google Scholar]
  166. MARCUS A. J., ULLMAN H. L., SAFIER L. B., BALLARD H. S. Platelet phosphatides. Their fatty acid and aldehyde composition and activity in different clotting systems. J Clin Invest. 1962 Dec;41:2198–2212. doi: 10.1172/JCI104679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. MacIntyre D. E., Gordon J. L. Calcium-dependent stimulation of platelet aggregation by PGE. Nature. 1975 Nov 27;258(5533):337–339. doi: 10.1038/258337a0. [DOI] [PubMed] [Google Scholar]
  168. MacIntyre D. E., Gordon J. L. Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins. Thromb Res. 1977 Dec;11(6):705–713. doi: 10.1016/0049-3848(77)90099-8. [DOI] [PubMed] [Google Scholar]
  169. MacIntyre D. E., Pearson J. D., Gordon J. L. Localisation and stimulation of prostacyclin production in vascular cells. Nature. 1978 Feb 9;271(5645):549–551. doi: 10.1038/271549a0. [DOI] [PubMed] [Google Scholar]
  170. Maca R. D., Hoak J. C. Endothelial injury and platelet aggregation assoicated with acute lipid mobilization. Lab Invest. 1974 May;30(5):589–595. [PubMed] [Google Scholar]
  171. Malmsten C., Hamberg M., Svensson J., Samuelsson B. Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1446–1450. doi: 10.1073/pnas.72.4.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Malmsten C., Kindahl H., Samuelsson B., Levy-Toledano S., Tobelem G., Caen J. P. Thromboxane synthesis and the platelet release reaction in Bernard-Soulier syndrome, thrombasthenia Glanzmann and Hermansky-Pudlak syndrome. Br J Haematol. 1977 Apr;35(4):511–520. doi: 10.1111/j.1365-2141.1977.tb00617.x. [DOI] [PubMed] [Google Scholar]
  173. Malmsten C. Some biological effects of prostaglandin endoperoxide analogs. Life Sci. 1976 Jan 15;18(2):169–176. doi: 10.1016/0024-3205(76)90021-7. [DOI] [PubMed] [Google Scholar]
  174. Marcus A. J., Weksler B. B., Jaffe E. A. Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells. J Biol Chem. 1978 Oct 25;253(20):7138–7141. [PubMed] [Google Scholar]
  175. Marquis N. R., Vigdahl R. L., Tavormina P. A. Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1. Biochem Biophys Res Commun. 1969 Sep 10;36(6):965–972. doi: 10.1016/0006-291x(69)90298-8. [DOI] [PubMed] [Google Scholar]
  176. Martin B. M., Feinman R. D., Detwiler T. C. Platelet stimulation by thrombin and other proteases. Biochemistry. 1975 Mar 25;14(6):1308–1314. doi: 10.1021/bi00677a032. [DOI] [PubMed] [Google Scholar]
  177. Martin B. M., Wasiewski W. W., Fenton J. W., 2nd, Detwiler T. C. Equilibrium binding of thrombin to platelets. Biochemistry. 1976 Nov 2;15(22):4886–4893. doi: 10.1021/bi00667a021. [DOI] [PubMed] [Google Scholar]
  178. Maseri A., L'Abbate A., Baroldi G., Chierchia S., Marzilli M., Ballestra A. M., Severi S., Parodi O., Biagini A., Distante A. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med. 1978 Dec 7;299(23):1271–1277. doi: 10.1056/NEJM197812072992303. [DOI] [PubMed] [Google Scholar]
  179. Massini P., Lüscher E. F. Some effects of ionophores for divalent cations on blood platelets. Comparison with the effects of thrombin. Biochim Biophys Acta. 1974 Nov 4;372(1):109–121. doi: 10.1016/0304-4165(74)90077-4. [DOI] [PubMed] [Google Scholar]
  180. Massini P., Lüscher E. F. The induction of the release reaction in human blood platelets by close cell contact. Thromb Diath Haemorrh. 1971;25(1):13–20. [PubMed] [Google Scholar]
  181. Miller O. V., Johnson R. A., Gorman R. R. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2. Prostaglandins. 1977 Apr;13(4):599–609. doi: 10.1016/0090-6980(77)90231-3. [DOI] [PubMed] [Google Scholar]
  182. Mills D. C., Macfarlane D. E. Stimulation of human platelet adenylate cyclase by prostaglandin D2. Thromb Res. 1974 Sep;5(3):401–412. doi: 10.1016/0049-3848(74)90176-5. [DOI] [PubMed] [Google Scholar]
  183. Mills D. C., Robb I. A., Roberts G. C. The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol. 1968 Apr;195(3):715–729. doi: 10.1113/jphysiol.1968.sp008484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Mills D. C., Smith J. B. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. Biochem J. 1971 Jan;121(2):185–196. doi: 10.1042/bj1210185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Minkes M., Stanford N., Chi M. M., Roth G. J., Raz A., Needleman P., Majerus P. W. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. J Clin Invest. 1977 Mar;59(3):449–454. doi: 10.1172/JCI108659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Miyamoto T., Ogino N., Yamamoto S., Hayaishi O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem. 1976 May 10;251(9):2629–2636. [PubMed] [Google Scholar]
  187. Miyamoto T., Yamamoto S., Hayaishi O. Prostaglandin synthetase system--resolution into oxygenase and isomerase components. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3645–3648. doi: 10.1073/pnas.71.9.3645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Moncada S., Bunting S., Mullane K., Thorogood P., Vane J. R., Raz A., Needleman P. Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins. 1977 Apr;13(4):611–618. doi: 10.1016/0090-6980(77)90232-5. [DOI] [PubMed] [Google Scholar]
  189. Moncada S., Gryglewski R. J., Bunting S., Vane J. R. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins. 1976 Nov;12(5):715–737. doi: 10.1016/0090-6980(76)90048-4. [DOI] [PubMed] [Google Scholar]
  190. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  191. Moncada S., Herman A. G., Higgs E. A., Vane J. R. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res. 1977 Sep;11(3):323–344. doi: 10.1016/0049-3848(77)90185-2. [DOI] [PubMed] [Google Scholar]
  192. Moncada S., Higgs E. A., Vane J. R. Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation. Lancet. 1977 Jan 1;1(8001):18–20. doi: 10.1016/s0140-6736(77)91655-5. [DOI] [PubMed] [Google Scholar]
  193. Moncada S., Korbut R., Bunting S., Vane J. R. Prostacyclin is a circulating hormone. Nature. 1978 Jun 29;273(5665):767–768. doi: 10.1038/273767a0. [DOI] [PubMed] [Google Scholar]
  194. Moncada S., Korbut R. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet. 1978 Jun 17;1(8077):1286–1289. doi: 10.1016/s0140-6736(78)91269-2. [DOI] [PubMed] [Google Scholar]
  195. Muenzer J., Weinbach E. C., Wolfe S. M. Oxygen consumption of human blood platelets. I. Effect of thrombin. Biochim Biophys Acta. 1975 Feb 17;376(2):237–242. doi: 10.1016/0005-2728(75)90015-8. [DOI] [PubMed] [Google Scholar]
  196. Muenzer J., Weinbach E. C., Wolfe S. M. Oxygen consumption of human blood platelets. II. Effect of inhibitors on thrombin-induced oxygen burst. Biochim Biophys Acta. 1975 Feb 17;376(2):243–248. doi: 10.1016/0005-2728(75)90016-x. [DOI] [PubMed] [Google Scholar]
  197. Murota S. I., Kawamura M., Morita I. Transformation of arachidonic acid into thromboxane B2 by the homogenates of activated macrophages. Biochim Biophys Acta. 1978 Mar 30;528(3):507–511. [PubMed] [Google Scholar]
  198. Murota S. I., Yokoi T., Morita I., Mori Y. Effect of various prostaglandins on the release of arachidonic acid from cultured fibroblasts. Biochem Biophys Res Commun. 1978 Jul 28;83(2):679–687. doi: 10.1016/0006-291x(78)91043-4. [DOI] [PubMed] [Google Scholar]
  199. Mustard J. F., Packham M. A. Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol Rev. 1970 Jun;22(2):97–187. [PubMed] [Google Scholar]
  200. Mürer E. H., Holme R. A study of the release of calcium from human blood platelets and its inhibition by metabolic inhibitors. N-ethylmaleimide and aspirin. Biochim Biophys Acta. 1970 Oct 27;222(1):197–205. doi: 10.1016/0304-4165(70)90365-x. [DOI] [PubMed] [Google Scholar]
  201. NORDOEY A., CHANDLER A. B. PLATELET THROMBOSIS INDUCED BY ADENOSINE DIPHOSPHATE IN THE RAT. Scand J Haematol. 1964;1:16–25. doi: 10.1111/j.1600-0609.1964.tb00002.x. [DOI] [PubMed] [Google Scholar]
  202. Nath N., Niewiarowski S., Joist J. H. Platelet factor 4--antiheparin protein releasable from platelets. Purification and properties. J Lab Clin Med. 1973 Nov;82(5):754–768. [PubMed] [Google Scholar]
  203. Needleman P., Bryan B., Wyche A., Bronson S. D., Eakins K., Ferrendelli J. A., Minkes M. Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensions. Prostaglandins. 1977 Nov;14(5):897–907. doi: 10.1016/0090-6980(77)90306-9. [DOI] [PubMed] [Google Scholar]
  204. Needleman P., Kulkarni P. S., Raz A. Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. Science. 1977 Jan 28;195(4276):409–412. doi: 10.1126/science.831285. [DOI] [PubMed] [Google Scholar]
  205. Needleman P., Minkes M., Raz A. Thromboxanes: selective biosynthesis and distinct biological properties. Science. 1976 Jul 9;193(4248):163–165. doi: 10.1126/science.945611. [DOI] [PubMed] [Google Scholar]
  206. Needleman P., Moncada S., Bunting S., Vane J. R., Hamberg M., Samuelsson B. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature. 1976 Jun 17;261(5561):558–560. doi: 10.1038/261558a0. [DOI] [PubMed] [Google Scholar]
  207. Needleman P., Raz A., Ferrendelli J. A., Minkes M. Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets. Proc Natl Acad Sci U S A. 1977 Apr;74(4):1716–1720. doi: 10.1073/pnas.74.4.1716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Nelson N. A., Jackson R. W., Au A. T., Wynalda D. J., Nishizawa E. E. Synthesis of dl-4,5,6-trinor-3,7-inter-m-phenylene-3oxaprostaglandins including one which inhibits platelet aggregation. Prostaglandins. 1975 Nov;10(5):795–806. doi: 10.1016/0090-6980(75)90008-8. [DOI] [PubMed] [Google Scholar]
  209. Nemerson Y., Pitlick F. A. The tissue factor pathway of blood coagulation. Prog Hemost Thromb. 1972;1:1–37. [PubMed] [Google Scholar]
  210. Nicolaou K. C., Barnette W. E., Gasic G. P., Magolda R. L. 6,9-thiaprostacyclin. A stable and biologically potent analogue of prostacyclin (PGI2) J Am Chem Soc. 1977 Nov 9;99(23):7736–7738. doi: 10.1021/ja00465a070. [DOI] [PubMed] [Google Scholar]
  211. Nicolaou K. C., Barnette W. E., Magolda R. L. Synthesis of prostaglandin H2 (PGH2) and prostacyclin (PGI2) analogs: tetrathia-PGH2 and PGI2-ketal methyl ester. Prostaglandins Med. 1978 Jul;1(1):96–97. doi: 10.1016/0161-4630(78)90081-2. [DOI] [PubMed] [Google Scholar]
  212. Nicolaou K. C., Magolda R. L., Smith J. B., Aharony D., Smith E. F., Lefer A. M. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2566–2570. doi: 10.1073/pnas.76.6.2566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Niewiarowski S., Kirby E. P., Stocker K. Throbocytin-a novel platelet activating enzyme from Bothrops atrox venom. Thromb Res. 1977 Jun;10(6):863–869. doi: 10.1016/0049-3848(77)90144-x. [DOI] [PubMed] [Google Scholar]
  214. Niewiarowski S., Regoeczi E., Stewart G. J., Senyl A. F., Mustard J. F. Platelet interaction with polymerizing fibrin. J Clin Invest. 1972 Mar;51(3):685–699. doi: 10.1172/JCI106857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Nijkamp F. P., Flower R. J., Moncada S., Vane J. R. Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids. Nature. 1976 Oct 7;263(5577):479–482. doi: 10.1038/263479a0. [DOI] [PubMed] [Google Scholar]
  216. Nordöy A., Hamlin J. T., Chandler A. B., Newland H. The influence of dietary fats on plasma and platelet lipids and ADP induced platelet thrombosis in the rat. Scand J Haematol. 1968;5(6):458–473. doi: 10.1111/j.1600-0609.1968.tb00867.x. [DOI] [PubMed] [Google Scholar]
  217. Nugteren D. H. Arachidonate lipoxygenase in blood platelets. Biochim Biophys Acta. 1975 Feb 20;380(2):299–307. doi: 10.1016/0005-2760(75)90016-8. [DOI] [PubMed] [Google Scholar]
  218. Nugteren D. H., Hazelhof E. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim Biophys Acta. 1973 Dec 20;326(3):448–461. doi: 10.1016/0005-2760(73)90145-8. [DOI] [PubMed] [Google Scholar]
  219. Nugteren D. H. Inhibition of prostaglandin biosynthesis by 8cis, 12trans, 14cis-eicosatrienoic acid and 5cis, 8cis, 12trans, 14cis-eicosatetraenoic acid. Biochim Biophys Acta. 1970 Jun 9;210(1):171–176. doi: 10.1016/0005-2760(70)90072-x. [DOI] [PubMed] [Google Scholar]
  220. Nurden A. T., Caen J. P. An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. Br J Haematol. 1974 Oct;28(2):253–260. doi: 10.1111/j.1365-2141.1974.tb06660.x. [DOI] [PubMed] [Google Scholar]
  221. Nurden A. T., Caen J. P. Role of surface glycoproteins in human platelet function. Thromb Haemost. 1976 Feb 29;35(1):139–150. [PubMed] [Google Scholar]
  222. O'Brien J. R. Effects of salicylates on human platelets. Lancet. 1968 Apr 13;1(7546):779–783. doi: 10.1016/s0140-6736(68)92228-9. [DOI] [PubMed] [Google Scholar]
  223. Oelz O., Oelz R., Knapp H. R., Sweetman B. J., Oates J. A. Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins. 1977 Feb;13(2):225–234. doi: 10.1016/0090-6980(77)90004-1. [DOI] [PubMed] [Google Scholar]
  224. Ogino N., Miyamoto T., Yamamoto S., Hayaishi O. Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme. J Biol Chem. 1977 Feb 10;252(3):890–895. [PubMed] [Google Scholar]
  225. Ogino N., Ohki S., Yamamoto S., Hayaishi O. Prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. Inactivation and activation by heme and other metalloporphyrins. J Biol Chem. 1978 Jul 25;253(14):5061–5068. [PubMed] [Google Scholar]
  226. Ogletree M. L., Smith J. B., Lefer A. M. Actions of prostaglandins on isolated perfused cat coronary arteries. Am J Physiol. 1978 Oct;235(4):H400–H406. doi: 10.1152/ajpheart.1978.235.4.H400. [DOI] [PubMed] [Google Scholar]
  227. Okuma M., Steiner M., Baldini G. Studies on lipid peroxides in platelets. II. Effect of aggregating agents and platelet antibody. J Lab Clin Med. 1971 May;77(5):728–742. [PubMed] [Google Scholar]
  228. PRINZMETAL M., KENNAMER R., MERLISS R., WADA T., BOR N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med. 1959 Sep;27:375–388. doi: 10.1016/0002-9343(59)90003-8. [DOI] [PubMed] [Google Scholar]
  229. Pace-Asciak C. R., Carrara M. C., Domazet Z. Identification of the major urinary metabolites of 6-ketoprostaglandin F1alpha (6K-PGF1alpha) in the rat. Biochem Biophys Res Commun. 1977 Sep 9;78(1):115–121. doi: 10.1016/0006-291x(77)91228-1. [DOI] [PubMed] [Google Scholar]
  230. Pace-Asciak C. R., Nashat M. Mechanistic studies on the biosynthesis of 6-ketoprostaglandin F1alpha. Biochim Biophys Acta. 1977 Jun 22;487(3):495–507. doi: 10.1016/0005-2760(77)90219-3. [DOI] [PubMed] [Google Scholar]
  231. Pace-Asciak C. R., Rangaraj G. Distribution of prostaglandin biosynthetic pathways in organs and tissues of the fetal lamb. Biochim Biophys Acta. 1978 Mar 30;528(3):512–514. doi: 10.1016/0005-2760(78)90042-5. [DOI] [PubMed] [Google Scholar]
  232. Pace-Asciak C. Letter: Isolation, structure, and biosynthesis of 6-ketoprostaglandin F1 alpha in the rat stomach. J Am Chem Soc. 1976 Apr 14;98(8):2348–2349. doi: 10.1021/ja00424a065. [DOI] [PubMed] [Google Scholar]
  233. Pace-Asciak C., Nashat M. Catabolism of an isolated, purified intermediate of prostaglandin biosynthesis by regions of the adult rat kidney. Biochim Biophys Acta. 1975 May 22;388(2):243–252. doi: 10.1016/0005-2760(75)90129-0. [DOI] [PubMed] [Google Scholar]
  234. Pace-Asciak C., Wolfe L. S. A novel prostaglandin derivative formed from arachidonic acid by rat stomach homogenates. Biochemistry. 1971 Sep 28;10(20):3657–3664. doi: 10.1021/bi00796a004. [DOI] [PubMed] [Google Scholar]
  235. Pace-Asciak C., Wolfe L. S. Inhibition of prostaglandin synthesis by oleic, linoleic and linolenic acids. Biochim Biophys Acta. 1968 Jul 1;152(4):784–787. doi: 10.1016/0005-2760(68)90126-4. [DOI] [PubMed] [Google Scholar]
  236. Packham M. A., Guccione M. A., Chang P. L., Mustard J. F. Platelet aggregation and release: effects of low concentrations of thrombin or collagen. Am J Physiol. 1973 Jul;225(1):38–47. doi: 10.1152/ajplegacy.1973.225.1.38. [DOI] [PubMed] [Google Scholar]
  237. Patrono C., Ciabattoni G., Crossi-Belloni D. Release of prostaglandin F1alpha and F2alpha from superfused platelets: quantitative evaluation of the inhibitory effects of some aspirin-like drugs. Prostaglandins. 1975 Apr;9(4):557–568. doi: 10.1016/0090-6980(75)90061-1. [DOI] [PubMed] [Google Scholar]
  238. Phillips D. R., Agin P. P. Platelet plasma membrane glycoproteins. Identification of a proteolytic substrate for thrombin. Biochem Biophys Res Commun. 1977 Apr 25;75(4):940–947. doi: 10.1016/0006-291x(77)91473-5. [DOI] [PubMed] [Google Scholar]
  239. Phillips D. R., Jenkins C. S., Lüscher E. F., Larrieu M. Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature. 1975 Oct 16;257(5527):599–600. doi: 10.1038/257599a0. [DOI] [PubMed] [Google Scholar]
  240. Pickett W. C., Cohen P. Mechanism of the thrombin-mediated burst in oxygen consumption by human platelets. J Biol Chem. 1976 Apr 25;251(8):2536–2538. [PubMed] [Google Scholar]
  241. Pickett W. C., Cohen P. Mechanism of the thrombin-mediated burst in oxygen consumption by human platelets. J Biol Chem. 1976 Apr 25;251(8):2536–2538. [PubMed] [Google Scholar]
  242. Pickett W. C., Jesse R. L., Cohen P. Initiation of phospholipase A2 activity in human platelets by the calcium ion ionophore A23187. Biochim Biophys Acta. 1976 Jan 18;486(1):209–213. doi: 10.1016/0005-2760(77)90086-8. [DOI] [PubMed] [Google Scholar]
  243. Piper P. J., Vane J. R. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature. 1969 Jul 5;223(5201):29–35. doi: 10.1038/223029a0. [DOI] [PubMed] [Google Scholar]
  244. Pistorius E. K., Axelrod B. Iron, an essential component of lipoxygenase. J Biol Chem. 1974 May 25;249(10):3183–3186. [PubMed] [Google Scholar]
  245. Pletscher A. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Br J Pharmacol Chemother. 1968 Jan;32(1):1–16. doi: 10.1111/j.1476-5381.1968.tb00423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Preston F. E., Emmanuel I. G., Winfield D. A., Malia R. G. Essential thrombocythaemia and peripheral gangrene. Br Med J. 1974 Aug 31;3(5930):548–552. doi: 10.1136/bmj.3.5930.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. Quick A. J. Salicylates and bleeding: the aspirin tolerance test. Am J Med Sci. 1966 Sep;252(3):265–269. doi: 10.1097/00000441-196609000-00003. [DOI] [PubMed] [Google Scholar]
  248. Raz A., Aharony D., Kenig-Wakshal R. Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Evidence for a common enzymatic pathway. Eur J Biochem. 1978 May 16;86(2):447–454. doi: 10.1111/j.1432-1033.1978.tb12327.x. [DOI] [PubMed] [Google Scholar]
  249. Raz A., Isakson P. C., Minkes M. S., Needleman P. Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator. J Biol Chem. 1977 Feb 10;252(3):1123–1126. [PubMed] [Google Scholar]
  250. Raz A., Kenig-Wakshal R., Schwartzman M. Effect of organic sulfur compounds on the chemical and enzymatic transformations of prostaglandin endoperoxide H2. Biochim Biophys Acta. 1977 Aug 24;488(2):322–329. doi: 10.1016/0005-2760(77)90190-4. [DOI] [PubMed] [Google Scholar]
  251. Raz A., Minkes M. S., Needleman P. Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction. Biochim Biophys Acta. 1977 Aug 24;488(2):305–311. doi: 10.1016/0005-2760(77)90188-6. [DOI] [PubMed] [Google Scholar]
  252. Reed P. W., Lardy H. A. A23187: a divalent cation ionophore. J Biol Chem. 1972 Nov 10;247(21):6970–6977. [PubMed] [Google Scholar]
  253. Reimers H. J., Kinlough-Rathbone R. L., Cazenave J. P., Senyi A. F., Hirsh J., Packham M. A., Mustard J. F. In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemost. 1976 Feb 29;35(1):151–166. [PubMed] [Google Scholar]
  254. Rittenhouse-Simmons S., Deykin D. The mobilization of arachidonic acid in platelets exposed to thrombin or ionophore A23187. Effects of adenosine triphosphate deprivation. J Clin Invest. 1977 Aug;60(2):495–498. doi: 10.1172/JCI108801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. Rittenhouse-Simmons S., Russell F. A., Deykin D. Mobilization of arachidonic acid in human platelets. Kinetics and Ca2+ dependency. Biochim Biophys Acta. 1977 Sep 28;488(3):370–380. doi: 10.1016/0005-2760(77)90196-5. [DOI] [PubMed] [Google Scholar]
  256. Rittenhouse-Simmons S., Russell R. A., Deykin D. Transfer of arachidonic acid to human platelet plasmalogen in response to thrombin. Biochem Biophys Res Commun. 1976 May 3;70(1):295–301. doi: 10.1016/0006-291x(76)91141-4. [DOI] [PubMed] [Google Scholar]
  257. Roberts L. J., 2nd, Sweetman B. J., Morgan J. L., Payne N. A., Oates J. A. Identification of the major urinary metabolite of thromboxane B2 in the monkey. Prostaglandins. 1977 Apr;13(4):631–647. doi: 10.1016/0090-6980(77)90234-9. [DOI] [PubMed] [Google Scholar]
  258. Roberts L. J., 2nd, Sweetman B. J., Oates J. A. Metabolism of thromboxane B2 in the monkey. J Biol Chem. 1978 Aug 10;253(15):5305–5318. [PubMed] [Google Scholar]
  259. Rome L. H., Lands W. E., Roth G. J., Majerus P. W. Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandins. Prostaglandins. 1976 Jan;11(1):23–30. doi: 10.1016/0090-6980(76)90169-6. [DOI] [PubMed] [Google Scholar]
  260. Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1207–1210. doi: 10.1073/pnas.71.4.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Roth G. J., Majerus P. W. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest. 1975 Sep;56(3):624–632. doi: 10.1172/JCI108132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  262. Roth G. J., Stanford N., Majerus P. W. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3073–3076. doi: 10.1073/pnas.72.8.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Roza M., Francke A. Soyabean lipoxygenase: an iron-containing enzyme. Biochim Biophys Acta. 1973 Nov 15;327(1):24–31. doi: 10.1016/0005-2744(73)90099-5. [DOI] [PubMed] [Google Scholar]
  264. Russell F. A., Deykin D. The effect of thrombin on the uptake and transformation of arachidonic acid by human platelets. Am J Hematol. 1976;1(1):59–70. doi: 10.1002/ajh.2830010107. [DOI] [PubMed] [Google Scholar]
  265. Rådegran K., Bergentz S. E., Lewis D. H., Ljungqvist U., Olsson P. Pulmonary effects of induced platelet aggregation. Intravascular obstruction or vasoconstriction? Scand J Clin Lab Invest. 1971 Dec;28(4):423–427. doi: 10.3109/00365517109095718. [DOI] [PubMed] [Google Scholar]
  266. SAMUELSSON B. ON THE INCORPORATION OF OXYGEN IN THE CONVERSION OF 8, 11, 14-EICOSATRIENOIC ACID TO PROSTAGLANDIN E1. J Am Chem Soc. 1965 Jul 5;87:3011–3013. doi: 10.1021/ja01091a043. [DOI] [PubMed] [Google Scholar]
  267. SPAET T. H., ZUCKER M. B. MECHANISM OF PLATELET PLUG FORMATION AND ROLE OF ADENOSINE DIPHOSPHATE. Am J Physiol. 1964 Jun;206:1267–1274. doi: 10.1152/ajplegacy.1964.206.6.1267. [DOI] [PubMed] [Google Scholar]
  268. Saba S. R., Mason R. G. Studies of an activity from endothelial cells that inhibits platelet aggregation, serotonin release, and clot retraction. Thromb Res. 1974 Dec;5(6):747–757. doi: 10.1016/0049-3848(74)90118-2. [DOI] [PubMed] [Google Scholar]
  269. Saba S. R., Zucker W. H., Mason R. G. Some properties of endothelial cells isolated from human umbilical cord vein. Ser Haematol. 1973;6(4):456–468. [PubMed] [Google Scholar]
  270. Salmon J. A., Smith D. R., Flower R. J., Moncada S., Vane J. R. Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. Biochim Biophys Acta. 1978 Mar 14;523(1):250–262. doi: 10.1016/0005-2744(78)90028-1. [DOI] [PubMed] [Google Scholar]
  271. Schick P. K., Kurica K. B., Chacko G. K. Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane. J Clin Invest. 1976 May;57(5):1221–1226. doi: 10.1172/JCI108390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  272. Sedar A. W., Silver M. J., Kocsis J. J., Smith J. B. Fatty acids and the initial events of endothelial damage seen by scanning and transmission electron microscopy. Atherosclerosis. 1978 Aug;30(4):273–284. doi: 10.1016/0021-9150(78)90120-x. [DOI] [PubMed] [Google Scholar]
  273. Seeman P. The membrane actions of anesthetics and tranquilizers. Pharmacol Rev. 1972 Dec;24(4):583–655. [PubMed] [Google Scholar]
  274. Shio H., Ramwell P. Effect of prostaglandin E 2 and aspirin on the secondary aggregation of human platelets. Nat New Biol. 1972 Mar 15;236(63):45–46. doi: 10.1038/newbio236045a0. [DOI] [PubMed] [Google Scholar]
  275. Siegl A. M., Smith J. B., Silver M. J., Nicolaou K. C., Ahern D. Selective binding site for [3H]prostacyclin on platelets. J Clin Invest. 1979 Feb;63(2):215–220. doi: 10.1172/JCI109292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  276. Silver M. J., Hoch W., Kocsis J. J., Ingerman C. M., Smith J. B. Arachidonic acid causes sudden death in rabbits. Science. 1974 Mar 15;183(4129):1085–1087. doi: 10.1126/science.183.4129.1085. [DOI] [PubMed] [Google Scholar]
  277. Silver M. J., Smith J. B., Ingerman C., Kocsis J. J. Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins. 1973 Dec;4(6):863–875. doi: 10.1016/0090-6980(73)90121-4. [DOI] [PubMed] [Google Scholar]
  278. Silver M. J., Smith J. B., Ingerman C., Kocsis J. J. Human blood prostaglandins: formation during clotting. Prostaglandins. 1972 Jun;1(6):429–436. doi: 10.1016/0090-6980(72)90011-1. [DOI] [PubMed] [Google Scholar]
  279. Skidgel R. A., Printz M. P. PGI2 production by rat blood vessels: diminished prostacyclin formation in veins compared to arteries. Prostaglandins. 1978 Jul;16(1):1–16. doi: 10.1016/0090-6980(78)90196-x. [DOI] [PubMed] [Google Scholar]
  280. Smith J. B., Ingerman C. M., Silver M. J. Formation of prostagland in D2 during endoperoxide-induced platelet aggregation. Thromb Res. 1976 Oct;9(4):413–418. doi: 10.1016/0049-3848(76)90141-9. [DOI] [PubMed] [Google Scholar]
  281. Smith J. B., Ingerman C. M., Silver M. J. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med. 1976 Jul;88(1):167–172. [PubMed] [Google Scholar]
  282. Smith J. B., Ingerman C. M., Silver M. J. Prostaglandins and precursors in platelet function. Ciba Found Symp. 1975;35:207–224. doi: 10.1002/9780470720172.ch10. [DOI] [PubMed] [Google Scholar]
  283. Smith J. B., Ingerman C., Kocsis J. J., Silver M. J. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest. 1974 May;53(5):1468–1472. doi: 10.1172/JCI107695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  284. Smith J. B., Ingerman C., Kocsis J. J., Silver M. J. Formation of prostaglandins during the aggregation of human blood platelets. J Clin Invest. 1973 Apr;52(4):965–969. doi: 10.1172/JCI107262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  285. Smith J. B., Ogletree M. L., Lefer A. M., Nicolaou J. C. Antibodies which antagonise the effects of prostacyclin. Nature. 1978 Jul 6;274(5666):64–65. doi: 10.1038/274064a0. [DOI] [PubMed] [Google Scholar]
  286. Smith J. B., Silver M. J., Ingerman C. M., Kocsis J. J. Prostaglandin D2 inhibits the aggregation of human platelets. Thromb Res. 1974 Sep;5(3):291–299. doi: 10.1016/0049-3848(74)90168-6. [DOI] [PubMed] [Google Scholar]
  287. Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971 Jun 23;231(25):235–237. doi: 10.1038/newbio231235a0. [DOI] [PubMed] [Google Scholar]
  288. Smith W. L., Lands W. E. Stimulation and blockade of prostaglandin biosynthesis. J Biol Chem. 1971 Nov;246(21):6700–6702. [PubMed] [Google Scholar]
  289. Solum N. O., Stormorken H. Influence of fibrinogen on the aggregation of washed human blood platelets induced by adenosine diphosphate, thrombin, collagen, and adrenaline. Scand J Clin Lab Invest. 1965;17(Suppl):170+–170+. [PubMed] [Google Scholar]
  290. Stibbe J., Ong G. L., Ten Hoor F., Nauta J., van der Plas P. M., Vergroesen A. J., De Jong D., Krenning-Douma E. Influence of prostaglandin E1 on platelet decrease in the heart-lung machine. Haemostasis. 1973;2(6):294–303. doi: 10.1159/000214035. [DOI] [PubMed] [Google Scholar]
  291. Stuart M. J., Murphy S., Oski F. A., Evans A. E., Donaldson M. H., Gardner F. H. Platelet function in recipients of platelets from donors ingesting aspirin. N Engl J Med. 1972 Nov 30;287(22):1105–1109. doi: 10.1056/NEJM197211302872201. [DOI] [PubMed] [Google Scholar]
  292. Sun F. F. Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane synthetase. Biochem Biophys Res Commun. 1977 Feb 21;74(4):1432–1440. doi: 10.1016/0006-291x(77)90602-7. [DOI] [PubMed] [Google Scholar]
  293. Sun F. F., Chapman J. P., McGuire J. C. Metabolism of prostaglandin endoperoxide in animal tissues. Prostaglandins. 1977;14(6):1055–1074. doi: 10.1016/0090-6980(77)90285-4. [DOI] [PubMed] [Google Scholar]
  294. Sun F. F., Taylor B. M. Metabolism of prostacyclin in rat. Biochemistry. 1978 Sep 19;17(19):4096–4101. doi: 10.1021/bi00612a035. [DOI] [PubMed] [Google Scholar]
  295. Svensson J., Hamberg M., Samuelsson B. On the formation and effects of thromboxane A2 in human platelets. Acta Physiol Scand. 1976 Nov;98(3):285–294. doi: 10.1111/j.1748-1716.1976.tb10313.x. [DOI] [PubMed] [Google Scholar]
  296. Svensson J., Hamberg M., Samuelsson B. Prostaglandin endoperoxides IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets. Acta Physiol Scand. 1975 Jun;94(2):222–228. doi: 10.1111/j.1748-1716.1975.tb05881.x. [DOI] [PubMed] [Google Scholar]
  297. Svensson J., Hamberg M. Thromboxane A2 and prostaglandin H2: potent stimulators of the swine coronary artery. Prostaglandins. 1976 Dec;12(6):943–950. doi: 10.1016/0090-6980(76)90128-3. [DOI] [PubMed] [Google Scholar]
  298. Tai H. H., Yuan B., Wu A. T. Transformation of arachidonate into 6-oxoprostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 by sheep lung microsomal fraction. Biochem J. 1978 Feb 15;170(2):441–444. doi: 10.1042/bj1700441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  299. Tansik R. L., Namm D. H., White H. L. Synthesis of prostaglandin 6-keto F1alpha by cultured aortic smooth muscle cells and stimulation of its formation in a coupled system with platelet lysates. Prostaglandins. 1978 Mar;15(3):399–408. doi: 10.1016/0090-6980(78)90123-5. [DOI] [PubMed] [Google Scholar]
  300. Tateson J. E., Moncada S., Vane J. R. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins. 1977 Mar;13(3):389–397. doi: 10.1016/0090-6980(77)90019-3. [DOI] [PubMed] [Google Scholar]
  301. Taylor P. L., Kelly R. W. 19-Hydroxylated E prostaglandins as the major prostaglandins of human semen. Nature. 1974 Aug 23;250(5468):665–667. doi: 10.1038/250665a0. [DOI] [PubMed] [Google Scholar]
  302. Thomas D. P. Effect of catecholamines on platelet aggregation caused by thrombin. Nature. 1967 Jul 15;215(5098):298–299. doi: 10.1038/215298a0. [DOI] [PubMed] [Google Scholar]
  303. Tollefsen D. M., Feagler J. R., Majerus P. W. The binding of thrombin to the surface of human platelets. J Biol Chem. 1974 Apr 25;249(8):2646–2651. [PubMed] [Google Scholar]
  304. Tomasi V., Meringolo C., Bartolini G., Orlandi M. Biosynthesis of prostacyclin in rat liver endothelial cells and its control by prostaglandin E2. Nature. 1978 Jun 22;273(5664):670–671. doi: 10.1038/273670a0. [DOI] [PubMed] [Google Scholar]
  305. Tomlinson R. V., Ringold H. J. Relationship between inhibition of prostaglandin synthesis and drug efficacy: support for the current theory on mode of action of aspirin-like drugs. Biochem Biophys Res Commun. 1972 Jan 31;46(2):552–559. doi: 10.1016/s0006-291x(72)80174-8. [DOI] [PubMed] [Google Scholar]
  306. Tschopp T. B., Weiss H. J., Baumgartner H. R. Interaction of thrombasthenic platelets with subendothelium: normal adhesion, absent aggregation. Experientia. 1975 Jan 15;31(1):113–116. doi: 10.1007/BF01924709. [DOI] [PubMed] [Google Scholar]
  307. Turner S. R., Tainer J. A., Lynn W. S. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature. 1975 Oct 23;257(5528):680–681. doi: 10.1038/257680a0. [DOI] [PubMed] [Google Scholar]
  308. VAN DORPD, BEERTHUIS R. K., NUGTEREN D. H., VONKEMAN H. THE BIOSYNTHESIS OF PROSTAGLANDINS. Biochim Biophys Acta. 1964 Jul 15;90:204–207. doi: 10.1016/0304-4165(64)90144-8. [DOI] [PubMed] [Google Scholar]
  309. Van der Ouderaa F. J., Buytenhek M., Nugteren D. H., Van Dorp D. A. Purification and characterisation of prostaglandin endoperoxide synthetase from sheep vesicular glands. Biochim Biophys Acta. 1977 May 25;487(2):315–331. doi: 10.1016/0005-2760(77)90008-x. [DOI] [PubMed] [Google Scholar]
  310. Vanderhoek J. Y., Lands W. E. Acetylenic inhibitors of sheep vesicular gland oxygenase. Biochim Biophys Acta. 1973 Feb 14;296(2):374–381. doi: 10.1016/0005-2760(73)90095-7. [DOI] [PubMed] [Google Scholar]
  311. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  312. Vargaftig B. B., Dao N. Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents. Pharmacology. 1971;6(2):99–108. doi: 10.1159/000136231. [DOI] [PubMed] [Google Scholar]
  313. Vargaftig B. B., Hai N. D. Selective inhibition by mepacrine of the release of "rabbit aorta contracting substance" evoked by the administration of bradykinin. J Pharm Pharmacol. 1972 Feb;24(2):159–161. doi: 10.1111/j.2042-7158.1972.tb08953.x. [DOI] [PubMed] [Google Scholar]
  314. Vargaftig B. B., Zirinis P. Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2. Nat New Biol. 1973 Jul 25;244(134):114–116. doi: 10.1038/newbio244114a0. [DOI] [PubMed] [Google Scholar]
  315. Vigdahl R. L., Marquis N. R., Tavormina P. A. Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium. Biochem Biophys Res Commun. 1969 Oct 22;37(3):409–415. doi: 10.1016/0006-291x(69)90930-9. [DOI] [PubMed] [Google Scholar]
  316. Vigdahl R. L., Mongin J., Jr, Marquis N. R. Platelet aggregation. IV. Platelet phosphodiesterase and its inhibition by vasodilators. Biochem Biophys Res Commun. 1971 Mar 19;42(6):1088–1094. doi: 10.1016/0006-291x(71)90016-7. [DOI] [PubMed] [Google Scholar]
  317. Vik-Mo H. Effects of acute myocardial ischaemia on platelet aggregation in the coronary sinus and aorta in dogs. Scand J Haematol. 1977 Jul;19(1):68–74. doi: 10.1111/j.1600-0609.1977.tb02720.x. [DOI] [PubMed] [Google Scholar]
  318. Vonkeman H., van Dorp D. A. The action of prostaglandin synthetase on 2-arachidonyl-lecithin. Biochim Biophys Acta. 1968 Oct 22;164(2):430–432. doi: 10.1016/0005-2760(68)90169-0. [DOI] [PubMed] [Google Scholar]
  319. Vreeken J., van Aken W. G. Spontaneous aggregation of blood platelets as a cause of idiopothic thrombosis and recurrent painful toes and fingers. Lancet. 1971 Dec 25;2(7739):1395–1397. [PubMed] [Google Scholar]
  320. Walsh P. N., Mills D. C., White J. G. Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol. 1977 Jun;36(2):287–296. doi: 10.1111/j.1365-2141.1977.tb00649.x. [DOI] [PubMed] [Google Scholar]
  321. Walsh P. N. Platelet coagulant activities and hemostasis: a hypothesis. Blood. 1974 Apr;43(4):597–605. [PubMed] [Google Scholar]
  322. Weiss H. J., Aledort L. M., Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest. 1968 Sep;47(9):2169–2180. doi: 10.1172/JCI105903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  323. Weiss H. J. Letter: Relation of the von Willebrand factor to the bleeding time. N Engl J Med. 1974 Aug 22;291(8):420–420. doi: 10.1056/NEJM197408222910817. [DOI] [PubMed] [Google Scholar]
  324. Weiss H. J. Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med. 1975 Sep 18;293(12):580–588. doi: 10.1056/NEJM197509182931204. [DOI] [PubMed] [Google Scholar]
  325. Weiss H. J., Willis A. L., Kuhn D., Brand H. Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion. Br J Haematol. 1976 Feb;32(2):257–272. doi: 10.1111/j.1365-2141.1976.tb00929.x. [DOI] [PubMed] [Google Scholar]
  326. Weksler B. B., Ley C. W., Jaffe E. A. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest. 1978 Nov;62(5):923–930. doi: 10.1172/JCI109220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  327. Weksler B. B., Marcus A. J., Jaffe E. A. Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3922–3926. doi: 10.1073/pnas.74.9.3922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  328. Wentzell B., Epand R. M. Stimulation of the release of prostaglandins from polymorphonuclear leukocytes by the calcium inophore A23187. FEBS Lett. 1978 Feb 15;86(2):255–258. doi: 10.1016/0014-5793(78)80574-2. [DOI] [PubMed] [Google Scholar]
  329. Wester J., Sixma J. J., Geuze J. J., van der Veen J. Morphology of the early hemostasis in human skin wounds: influence of acetylsalicylic acid. Lab Invest. 1978 Sep;39(3):298–311. [PubMed] [Google Scholar]
  330. Westwick J., Webb H. Selective antagonism of prostaglandin (PG) E1, PGD2 and prostacyclin (PGI2) on human and rabbit platelets by di-4-phloretin phosphate (DPP). Thromb Res. 1978 Jun;12(6):973–978. doi: 10.1016/0049-3848(78)90053-1. [DOI] [PubMed] [Google Scholar]
  331. White J. G., Rao G. H., Gerrard J. M. Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. Am J Pathol. 1974 Nov;77(2):135–149. [PMC free article] [PubMed] [Google Scholar]
  332. White J. G., Witkop C. J. Effects of normal and aspirin platelets on defective secondary aggregation in the Hermansky-Pudlak syndrome. A test for storage pool deficient platelets. Am J Pathol. 1972 Jul;68(1):57–66. [PMC free article] [PubMed] [Google Scholar]
  333. Whittaker N., Bunting S., Salmon J., Moncada S., Vane J. R., Johnson R. A., Morton D. R., Kinner J. H., Gorman R. R., McGuire J. C. The chemical structure of prostaglandin X (prostacyclin). Prostaglandins. 1976 Dec;12(6):915–928. doi: 10.1016/0090-6980(76)90126-x. [DOI] [PubMed] [Google Scholar]
  334. Whittle B. J., Moncada S., Vane J. R. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins. 1978 Sep;16(3):373–388. doi: 10.1016/0090-6980(78)90216-2. [DOI] [PubMed] [Google Scholar]
  335. Whorton A. R., Smigel M., Oates J. A., Frölich J. C. Regional differences in prostacyclin formation by the kidney. Prostacyclin is a major prostaglandin of renal cortex. Biochim Biophys Acta. 1978 Apr 28;529(1):176–180. doi: 10.1016/0005-2760(78)90116-9. [DOI] [PubMed] [Google Scholar]
  336. Willis A. L., Comai K., Kuhn D. C., Paulsrud J. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo. Prostaglandins. 1974 Dec 25;8(6):509–519. doi: 10.1016/0090-6980(74)90063-x. [DOI] [PubMed] [Google Scholar]
  337. Willis A. L., Kuhn D. C. A new potential mediator of arterial thrombosis whose biosynthesis is inhibited by aspirin. Prostaglandins. 1973 Jul;4(1):127–130. doi: 10.1016/0090-6980(73)90062-2. [DOI] [PubMed] [Google Scholar]
  338. Willis A. L., Vane F. M., Kuhn D. C., Scott C. G., Petrin M. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Prostaglandins. 1974 Dec 25;8(6):453–507. doi: 10.1016/0090-6980(74)90062-8. [DOI] [PubMed] [Google Scholar]
  339. Wlodawer P., Hammarström S. Thromboxane synthase from bovine lung--solubilization and partial purification. Biochem Biophys Res Commun. 1978 Feb 14;80(3):525–532. doi: 10.1016/0006-291x(78)91600-5. [DOI] [PubMed] [Google Scholar]
  340. Wolfe L. S., Rostworowski K., Marion J. Endogenous formation of the prostaglandin endoperoxide metabolite, thromboxane B2, by brain tissue. Biochem Biophys Res Commun. 1976 Jun 7;70(3):907–913. doi: 10.1016/0006-291x(76)90677-x. [DOI] [PubMed] [Google Scholar]
  341. Wong P. Y., Sun F. F., McGiff J. C. Metabolism of prostacyclin in blood vessels. J Biol Chem. 1978 Aug 25;253(16):5555–5557. [PubMed] [Google Scholar]
  342. Workman E. F., Jr, White G. C., 2nd, Lundblad R. L. High affinity binding of thrombin to platelets. Inhibition by tetranitromethane and heparin. Biochem Biophys Res Commun. 1977 Apr 25;75(4):925–932. doi: 10.1016/0006-291x(77)91471-1. [DOI] [PubMed] [Google Scholar]
  343. Wu K. K., Hoak J. C. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet. 1974 Oct 19;2(7886):924–926. doi: 10.1016/s0140-6736(74)91131-3. [DOI] [PubMed] [Google Scholar]
  344. Yoshimoto T., Yamamoto S., Hayaishi O. Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles. Prostaglandins. 1978 Oct;16(4):529–540. doi: 10.1016/0090-6980(78)90183-1. [DOI] [PubMed] [Google Scholar]
  345. Yoshimoto T., Yamamoto S., Okuma M., Hayaishi O. Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets. J Biol Chem. 1977 Aug 25;252(16):5871–5874. [PubMed] [Google Scholar]
  346. Ziboh V. A. Biosynthesis of prostaglandin E 2 in human skin: subcellular localization and inhibition by unsaturated fatty acids and anti-inflammatory drugs. J Lipid Res. 1973 Jul;14(4):377–384. [PubMed] [Google Scholar]
  347. Ziboh V. A., Vanderhoek J. Y., Lands W. E. Inhibition of sheep vesicular gland oxygenase by unsaturated fatty acids from skin of essential fatty acid deficient rats. Prostaglandins. 1974 Feb 10;5(3):233–240. doi: 10.1016/0090-6980(74)90050-1. [DOI] [PubMed] [Google Scholar]
  348. Zucker M. B., Pert J. H., Hilgartner M. W. Platelet function in a patient with thrombasthenia. Blood. 1966 Oct;28(4):524–534. [PubMed] [Google Scholar]
  349. Zucker M. B., Peterson J. Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. J Lab Clin Med. 1970 Jul;76(1):66–75. [PubMed] [Google Scholar]
  350. Zucker M. B., Peterson J. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc Soc Exp Biol Med. 1968 Feb;127(2):547–551. doi: 10.3181/00379727-127-32737. [DOI] [PubMed] [Google Scholar]
  351. de Deckere E. A., Nugteren D. H., Ten Hoor F. Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart. Nature. 1977 Jul 14;268(5616):160–163. doi: 10.1038/268160a0. [DOI] [PubMed] [Google Scholar]
  352. von Euler U. S. On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin). J Physiol. 1936 Nov 6;88(2):213–234. doi: 10.1113/jphysiol.1936.sp003433. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES